$30.34
1.30%
Nasdaq, Aug 29, 10:00 pm CET
ISIN
US92337F1075
Symbol
VCYT

Veracyte Inc Target price 2025 - Analyst rating & recommendation

Veracyte Inc Classifications & Recommendation:

Buy
83%
Hold
11%
Sell
6%

Veracyte Inc Price Target

Target Price $42.84
Price $30.34
Potential
Number of Estimates 11
11 Analysts have issued a price target Veracyte Inc 2026 . The average Veracyte Inc target price is $42.84. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 18 analysts: 15 Analysts recommend Veracyte Inc to buy, 2 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Veracyte Inc stock has an average upside potential 2026 of . Most analysts recommend the Veracyte Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 445.76 509.02
23.46% 14.19%
EBITDA Margin 6.32% 22.12%
202.32% 249.90%
Net Margin 5.42% 5.79%
126.28% 6.92%

13 Analysts have issued a sales forecast Veracyte Inc 2025 . The average Veracyte Inc sales estimate is

$509m
Unlock
. This is
6.24% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$526m 9.81%
Unlock
, the lowest is
$481m 0.47%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $446m 23.46%
2025
$509m 14.19%
Unlock
2026
$558m 9.68%
Unlock
2027
$610m 9.32%
Unlock
2028
$673m 10.30%
Unlock
2029
$726m 7.86%
Unlock

13 Analysts have issued an Veracyte Inc EBITDA forecast 2025. The average Veracyte Inc EBITDA estimate is

$113m
Unlock
. This is
144.88% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$118m 155.56%
Unlock
, the lowest is
$106m 130.98%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $28.2m 273.25%
2025
$113m 299.65%
Unlock
2026
$131m 16.00%
Unlock
2027
$150m 14.58%
Unlock
2028
$174m 16.05%
Unlock
2029
$197m 13.51%
Unlock

EBITDA Margin

2024 6.32% 202.32%
2025
22.12% 249.90%
Unlock
2026
23.40% 5.79%
Unlock
2027
24.52% 4.79%
Unlock
2028
25.80% 5.22%
Unlock
2029
27.15% 5.23%
Unlock

13 Veracyte Inc Analysts have issued a net profit forecast 2025. The average Veracyte Inc net profit estimate is

$29.5m
Unlock
. This is
11.85% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$31.4m 19.06%
Unlock
, the lowest is
$27.0m 2.35%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $24.1m 132.45%
2025
$29.5m 22.04%
Unlock
2026
$66.5m 125.87%
Unlock
2027
$105m 57.84%
Unlock
2028
$171m 62.97%
Unlock
2029
$188m 9.60%
Unlock

Net Margin

2024 5.42% 126.28%
2025
5.79% 6.92%
Unlock
2026
11.92% 105.87%
Unlock
2027
17.21% 44.38%
Unlock
2028
25.42% 47.70%
Unlock
2029
25.83% 1.61%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.31 0.37
130.39% 19.35%
P/E 80.94
EV/Sales 4.06

13 Analysts have issued a Veracyte Inc forecast for earnings per share. The average Veracyte Inc EPS is

$0.37
Unlock
. This is
12.12% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.40 21.21%
Unlock
, the lowest is
$0.34 3.03%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.31 130.39%
2025
$0.37 19.35%
Unlock
2026
$0.85 129.73%
Unlock
2027
$1.34 57.65%
Unlock
2028
$2.18 62.69%
Unlock
2029
$2.39 9.63%
Unlock

P/E ratio

Current 91.94 301.12%
2025
80.94 11.96%
Unlock
2026
35.84 55.72%
Unlock
2027
22.71 36.64%
Unlock
2028
13.93 38.66%
Unlock
2029
12.71 8.76%
Unlock

Based on analysts' sales estimates for 2025, the Veracyte Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.31 22.48%
2025
4.06 5.82%
Unlock
2026
3.70 8.83%
Unlock
2027
3.39 8.53%
Unlock
2028
3.07 9.34%
Unlock
2029
2.85 7.29%
Unlock

P/S ratio

Current 4.98 19.02%
2025
4.69 5.87%
Unlock
2026
4.28 8.83%
Unlock
2027
3.91 8.53%
Unlock
2028
3.55 9.34%
Unlock
2029
3.29 7.29%
Unlock

Current Veracyte Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
UBS
Locked
Locked
Locked May 08 2025
Needham
Locked
Locked
Locked May 08 2025
Guggenheim
Locked
Locked
Locked Apr 09 2025
Stephens & Co.
Locked
Locked
Locked Mar 26 2025
Craig-Hallum
Locked
Locked
Locked Mar 20 2025
Guggenheim
Locked
Locked
Locked Feb 25 2025
Needham
Locked
Locked
Locked Feb 25 2025
Analyst Rating Date
Locked
UBS:
Locked
Locked
May 08 2025
Locked
Needham:
Locked
Locked
May 08 2025
Locked
Guggenheim:
Locked
Locked
Apr 09 2025
Locked
Stephens & Co.:
Locked
Locked
Mar 26 2025
Locked
Craig-Hallum:
Locked
Locked
Mar 20 2025
Locked
Guggenheim:
Locked
Locked
Feb 25 2025
Locked
Needham:
Locked
Locked
Feb 25 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today